Zobrazeno 1 - 10
of 254
pro vyhledávání: '"Gary E, Raskob"'
Autor:
Gary E. Raskob
Publikováno v:
Bleeding, Thrombosis and Vascular Biology, Vol 3, Iss s1 (2024)
Anticoagulant therapy is recommended for cancer-related venous thromboembolism (VTE). Recurrent VTE prevention is the main goal of this treatment. The majority of evidence-based practice guidelines recommend anticoagulant treatment for at least 6 mon
Externí odkaz:
https://doaj.org/article/dc47c446a0eb45aca6ff0af9ceec6de3
Autor:
Alex C. Spyropoulos, Gary E. Raskob, Theodore E. Spiro, Wentao Lu, Yoriko De Sanctis, John Albanese, Alexandre Mebazaa, Elliot S. Barnathan
Publikováno v:
TH Open, Vol 06, Iss 04, Pp e304-e308 (2022)
This post hoc subgroup analysis examined efficacy and safety outcomes with extended thromboprophylaxis rivaroxaban compared with in-hospital enoxaparin in 2,078 patients from the MAGELLAN study who had a hospitalization for heart failure or a history
Externí odkaz:
https://doaj.org/article/c30a282dfc12451e8dc11369d84e91b0
Autor:
Gary E. Raskob, Walter Ageno, Gregory Albers, C. Gregory Elliott, Jonathan Halperin, Gregory Maynard, Philippe Gabriel Steg, Jeffrey I. Weitz, John Albanese, Zhong Yuan, Bennett Levitan, Wentao Lu, Eun Young Suh, Theodore Spiro, Concetta Lipardi, Elliot S. Barnathan, Alex C. Spyropoulos
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 20 (2022)
Background Venous thromboembolism (VTE) often occurs after hospitalization in medically ill patients, but the population benefit–risk of extended thromboprophylaxis remains uncertain. Methods and Results The MARINER (Medically Ill Patient Assessmen
Externí odkaz:
https://doaj.org/article/3f35590df43c41208e8ddc289edabcaa
Autor:
Alex C. Spyropoulos, Mark Goldin, Walter Ageno, Gregory W. Albers, C. Gregory Elliott, William R. Hiatt, Jonathan L. Halperin, Gregory Maynard, P. Gabriel Steg, Jeffrey I. Weitz, Theodore E. Spiro, Wentao Lu, Jessica Marsigliano, Gary E. Raskob, Elliot S. Barnathan
Publikováno v:
TH Open, Vol 06, Iss 03, Pp e177-e183 (2022)
Background The MARINER trial evaluated whether postdischarge thromboprophylaxis with rivaroxaban could reduce the primary outcome of symptomatic venous thromboembolism (VTE) or VTE-related death in acutely ill medical patients at risk for VTE. Althou
Externí odkaz:
https://doaj.org/article/8d224873bb1841ca8d9854b241be5ec7
Autor:
Gary E. Raskob, Alex C. Spyropoulos, Theodore E. Spiro, Wentao Lu, Zhong Yuan, Bennett Levitan, Eunyoung Suh, Elliot S. Barnathan
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 22 (2021)
Background Thromboprophylaxis extended after hospital discharge in medically ill patients currently is not recommended by practice guidelines because of uncertainty about the benefit for preventing major or fatal thromboembolic events, and the risk o
Externí odkaz:
https://doaj.org/article/b3ae24eeae734c9d9ca797881cf8076b
Autor:
Concetta Lipardi MD, PhD, C. Gregory Elliott MD, Chiara L. Sugarmann BSN, MSHS, Lloyd Haskell MD, Alex C. Spyropoulos MD, Gary E. Raskob PhD, Jianfeng Xu PhD, Wentao Lu PhD, Jessica Marsigliano BS, Theodore Spiro MD, Zhong Yuan MD, PhD, Shujian Wu MD, PhD, Elliot S. Barnathan MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
Background: Bronchiectasis is a chronic inflammation of the bronchi with recurrent infections and hemoptysis. The MAGELLAN study compared oral rivaroxaban, 10 mg once daily (QD), for 35 ± 4 days with subcutaneous enoxaparin 40 mg QD for 10 ± 4 days
Externí odkaz:
https://doaj.org/article/1fd0b5a345ce4677b3379b0cff1e47c1
Autor:
Gary E. Raskob, Alex C. Spyropoulos, Alexander T. Cohen, Jeffrey I. Weitz, Walter Ageno, Yoriko De Sanctis, Wentao Lu, Jianfeng Xu, John Albanese, Chiara Sugarmann, Traci Weber, Concetta Lipardi, Theodore E. Spiro, Elliot S. Barnathan
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 5 (2021)
Background Asymptomatic proximal deep vein thrombosis (DVT) is an end point frequently used to evaluate the efficacy of anticoagulant thromboprophylaxis in medical patients. Recently, the clinical relevance of asymptomatic DVT has been challenged. Me
Externí odkaz:
https://doaj.org/article/76037fab5c754e27b468a9743e724d78
Autor:
Alex C. Spyropoulos, Concetta Lipardi, Jianfeng Xu, Colleen Peluso, Theodore E. Spiro, Yoriko De Sanctis, Elliot S. Barnathan, Gary E. Raskob
Publikováno v:
TH Open, Vol 04, Iss 01, Pp e59-e65 (2020)
An individualized approach to identify acutely ill medical patients at increased risk of venous thromboembolism (VTE) and a low risk of bleeding to optimize the benefit and risk of extended thromboprophylaxis (ET) is needed. The International Medical
Externí odkaz:
https://doaj.org/article/3770033c4d1b43058b978ef08e426bb1
Autor:
Gary E. Raskob, Aaron M. Wendelboe, Janis Campbell, Lance Ford, Kai Ding, Dale W. Bratzler, Micah McCumber, Alys Adamski, Karon Abe, Michele G. Beckman, Nimia L. Reyes, Lisa C. Richardson
Publikováno v:
Journal of Thrombosis and Haemostasis. 20:2366-2378
Data on the population-based incidence of cancer-associated venous thromboembolism (VTE) from racially diverse populations are limited.To evaluate the incidence and burden of cancer-associated VTE, including demographic and racial subgroups in the ge
Autor:
Alex C. Spyropoulos MD, Concetta Lipardi MD, PhD, Jianfeng Xu PhD, Wentao Lu PhD, Eunyoung Suh PhD, Zhong Yuan MD, PhD, Bennett Levitan MD, PhD, Chiara Sugarmann BSN, MSHS, Yoriko De Sanctis MS, Theodore E. Spiro MD, Elliot S. Barnathan MD, Gary E. Raskob PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Acutely ill medical patients are at risk of venous thromboembolism (VTE) and VTE-related mortality during hospitalization and posthospital discharge, but widespread adoption of extended thromboprophylaxis has not occurred. We analyzed a subpopulation
Externí odkaz:
https://doaj.org/article/08695681e70f4066959cc88d3eb01f44